Nienhuis HH - Search Results

1

Consideration of breast cancer subtype in targeting the androgen receptor.

Venema CM, Bense RD, Steenbruggen TG, Nienhuis HH, Qiu SQ, van Kruchten M, Brown M, Tamimi RM, Hospers GAP, Schröder CP, Fehrmann RSN, de Vries EGE. Venema CM, et al. Among authors: nienhuis hh. Pharmacol Ther. 2019 Aug;200:135-147. doi: 10.1016/j.pharmthera.2019.05.005. Epub 2019 May 8. Pharmacol Ther. 2019. PMID: 31077689 Free article. Review.

2

Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.

Nienhuis HH, Gaykema SB, Timmer-Bosscha H, Jalving M, Brouwers AH, Lub-de Hooge MN, van der Vegt B, Overmoyer B, de Vries EG, Schröder CP. Nienhuis HH, et al. Pharmacol Ther. 2015 Mar;147:63-79. doi: 10.1016/j.pharmthera.2014.11.004. Epub 2014 Nov 6. Pharmacol Ther. 2015. PMID: 25444756 Review.

3

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid.

Nienhuis HH, Arjaans M, Timmer-Bosscha H, de Vries EG, Schröder CP. Nienhuis HH, et al. Oncotarget. 2015 Sep 15;6(27):24436-47. doi: 10.18632/oncotarget.4421. Oncotarget. 2015. PMID: 26203666 Free PMC article.

4

¹⁸F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients.

Nienhuis HH, van Kruchten M, Elias SG, Glaudemans AWJM, de Vries EFJ, Bongaerts AHH, Schröder CP, de Vries EGE, Hospers GAP. Nienhuis HH, et al. J Nucl Med. 2018 Aug;59(8):1212-1218. doi: 10.2967/jnumed.117.198846. Epub 2018 Mar 30. J Nucl Med. 2018. PMID: 29602822 Free article.

5

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.

Qiu SQ, van Rooijen J, Nienhuis HH, van der Vegt B, Timmer-Bosscha H, van Leeuwen-Stok E, Walenkamp AME, van Deurzen CHM, de Bock GH, de Vries EGE, Schröder CP. Qiu SQ, et al. Among authors: nienhuis hh. Breast Cancer Res. 2020 Mar 18;22(1):30. doi: 10.1186/s13058-020-01266-x. Breast Cancer Res. 2020. PMID: 32188473 Free PMC article.

6

Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.

Terwisscha van Scheltinga AG, Berghuis P, Nienhuis HH, Timmer-Bosscha H, Pot L, Gaykema SB, Lub-de Hooge MN, Kosterink JG, de Vries EG, Schröder CP. Terwisscha van Scheltinga AG, et al. Among authors: nienhuis hh. Eur J Cancer. 2014 Sep;50(14):2508-16. doi: 10.1016/j.ejca.2014.06.008. Epub 2014 Jul 12. Eur J Cancer. 2014. PMID: 25027745

7

Luminal breast cancer metastasis is dependent on estrogen signaling.

Ganapathy V, Banach-Petrosky W, Xie W, Kareddula A, Nienhuis H, Miles G, Reiss M. Ganapathy V, et al. Clin Exp Metastasis. 2012 Jun;29(5):493-509. doi: 10.1007/s10585-012-9466-4. Epub 2012 Mar 17. Clin Exp Metastasis. 2012. PMID: 22427027 Free PMC article.

8

Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study.

Spierings J, Nienhuis H, van Lieshout E, van Laar JM, Pieterse AH. Spierings J, et al. J Scleroderma Relat Disord. 2022 Feb;7(1):42-48. doi: 10.1177/23971983211043311. Epub 2021 Sep 8. J Scleroderma Relat Disord. 2022. PMID: 35382449 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page